Company / Working Capital per Share
Rapport Therapeutics, Inc. Working Capital per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$14.52
FY2024
5-year range
$14.52 / $94.35
FY2023-FY2024
Trend
-84.6%
vs FY2023
Sector context
#32 of 210
Health Care
What the data says
Rapport Therapeutics, Inc.'s working capital per share of $14.52 is higher than 85% of companies in the Health Care sector (FY2024).
Based on SEC 10-K filings.
14.52 in FY2024. Top quartile in the Health Care sector.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 210This company $14.52 Sector average $146.86
▼
-90.1% below sector average
Key checks
Key Insights
- In FY2024, working capital per share decreased 84.6% year-over-year.
- Ranks #32 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 13.36 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $14.52 | -84.6% |
| FY2023 | $94.35 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026